NEWLAND PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.94 CNY | -0.14% |
|
+2.50% | -6.22% |
Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -6.22% | 538M | |
| +50.70% | 791B | |
| +41.96% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +18.02% | 246B | |
| +1.27% | 225B | |
| +11.95% | 218B | |
| +3.68% | 160B |
- Stock Market
- Equities
- 301277 Stock
- News Newland Pharmaceutical Co., Ltd.
- Newland Pharmaceutical Gets Nod to Market Moxifloxacin Hydrochloride